KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Tax Provisions (2016 - 2025)

Boston Scientific's Tax Provisions history spans 17 years, with the latest figure at $31.0 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 34.78% year-over-year to $31.0 million; the TTM value through Dec 2025 reached $493.0 million, up 13.07%, while the annual FY2025 figure was $493.0 million, 13.07% up from the prior year.
  • Tax Provisions for Q4 2025 was $31.0 million at Boston Scientific, down from $183.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $255.0 million in Q4 2022 and bottomed at -$37.0 million in Q2 2021.
  • The 5-year median for Tax Provisions is $91.5 million (2022), against an average of $90.0 million.
  • The largest annual shift saw Tax Provisions plummeted 233.33% in 2021 before it surged 2200.0% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $26.0 million in 2021, then soared by 880.77% to $255.0 million in 2022, then plummeted by 99.61% to $1.0 million in 2023, then soared by 2200.0% to $23.0 million in 2024, then skyrocketed by 34.78% to $31.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Tax Provisions are $31.0 million (Q4 2025), $183.0 million (Q3 2025), and $146.0 million (Q2 2025).